1-20 of 23
Jared Henderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim PET-adapted de-escalation chemotherapy regimen for advanced stage classical Hodgkin lymphoma using brentuximab vedotin, pembrolizumab, doxorubicin, and dacarbazine: Phase 2 study

Free
Hun Lee, Gregory Ravizzini, Jenna Wixom, Ayushi Chauhan, Luis Fayad, Ranjit Nair, Jason Westin, Jared Henderson, Eslam Aboismail, Christopher Flowers, Michael Wang, Luis Malpica Castillo
Journal: Blood
Blood (2025) 146 (Supplement 1): 153.
https://doi.org/10.1182/blood-2025-153
Published: 2025
Journal Articles

Integrative profiling of t-follicular helper cells heterogeneity and tumor microenvironment signatures in angioimmunoblastic T cell lymphoma

Free
Tania Sainz, Vakul Mohanty, Yuchen Pan, Xuehong Gui, Vishal Sahu, Anna Casasent, Akshay Basi, Claudia Kettlun, Christopher Pacheco, Ashley Wilson, Juan Andres Donoso, Aniruddha Mundhada, Jared Henderson, Yago Nieto, Jared Burks, Michael R Green, Ken Chen, Francisco Vega
Journal: Blood
Blood (2025) 146 (Supplement 1): 555.
https://doi.org/10.1182/blood-2025-555
Published: 2025
Journal Articles

primary analysis of the smart stop trial: Lenalidomide, tafasitamab, rituximab, and acalabrutinib alone and with combination chemotherapy in newly diagnosed diffuse large B-cell lymphoma

Free
Jason Westin, Luis Fayad, Raphael Steiner, Sairah Ahmed, Preetesh Jain, Luis Malpica, Ranjit Nair, Sattva Neelapu, Jared Henderson, Frederick Hagemeister, Maria Rodriguez, Chijioke Nze, Fateeha Furqan, Ayushi Chauhan, Mark Hamilton, Anath Lionel, Francisco Vega, Jisha Tom, Isak Durmic, Gita Masand, Rhanna Wilson, Cara Blyth, Christopher Flowers, Michael R Green, Dai Chihara
Journal: Blood
Blood (2025) 146 (Supplement 1): 477.
https://doi.org/10.1182/blood-2025-477
Published: 2025
Journal Articles

Durable responses in the updated 2-year follow-up of patients from a single-center with Relapsed/Refractory peripheral T-cell lymphoma treated with golidocitinib

Free
Eduardo Edelman Saul, Jessie Xu, Casey Bermack, Cathrine Paras, Jared Henderson, Kristofer Jennings, Bryan Valcarcel, Dr. Mohammad Abdul-Jaber Abdulla, Luis Fayad, Hun Lee, Preetesh Jain, Ranjit Nair, Michael Wang, Swami Iyer, Christopher Flowers, Luis Malpica
Journal: Blood
Blood (2025) 146 (Supplement 1): 5422.
https://doi.org/10.1182/blood-2025-5422
Published: 2025
Journal Articles

Germline variants and their role in the pathogenesis of immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) in adult lymphoma patients

Free
Anath Lionel, Cuong Le, Jianlong Liao, Sushanth Gouni, Xubin Li, Faezeh Darbaniyan, Jared Henderson, Ajlan Al Zaki, Federico Mario Aletti, Christen Dillard, Krina Patel, Amy Ayers, Misha Hawkins, Frederick Hagemeister, Maria Rodriguez, Hun Lee, Luis Fayad, Ranjit Nair, Luis Malpica, Chijioke Nze, Preetesh Jain, Michael Wang, Elizabeth Shpall, Partow Kebriaei, Swami Iyer, Dai Chihara, Paolo Strati, Jason Westin, Christopher Flowers, Sairah Ahmed, Linghua Wang, Michael R Green, Sattva Neelapu
Journal: Blood
Blood (2025) 146 (Supplement 1): 806.
https://doi.org/10.1182/blood-2025-806
Published: 2025
Journal Articles

A Phase II, single-center, single-arm study evaluating the safety and efficacy of golidocitinib in the management of newly diagnosed PTCL (GOLDEN Study)

Free
Eduardo Edelman Saul, Jessie Xu, Casey Bermack, Cathrine Paras, Jared Henderson, Kristofer Jennings, Bryan Valcarcel, Dr. Mohammad Abdul-Jaber Abdulla, Luis Fayad, Hun Lee, Preetesh Jain, Ranjit Nair, Michael Wang, Swami Iyer, Christopher Flowers, Luis Malpica
Journal: Blood
Blood (2025) 146 (Supplement 1): 5434.
https://doi.org/10.1182/blood-2025-5434
Published: 2025
Journal Articles

Long-term clinical outcomes from the smart start trial: Rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma

Free
Eduardo Edelman Saul, Karan Chohan, Richard Davis, F. B. Hagemeister, Raphael Steiner, Luis Fayad, Sairah Ahmed, Maria Rodriguez, Swami Iyer, Ranjit Nair, Francisco Vega, Dai Chihara, Paolo Strati, Preetesh Jain, Luis Malpica, Chijioke Nze, Fateeha Furqan, Ayushi Chauhan, Mark Hamilton, Jared Henderson, Anath Lionel, Christopher Flowers, Sattva Neelapu, Michael R Green, Jason Westin
Journal: Blood
Blood (2025) 146 (Supplement 1): 3691.
https://doi.org/10.1182/blood-2025-3691
Published: 2025
Journal Articles

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Free
Hun Ju Lee, Gregory Ravizzini, Eslam Aboismail, Jenna Wixom, Jared Henderson, Luis E. Fayad, Sairah Ahmed, Ranjit Nair, Jason R. Westin, Swaminathan P Iyer, Chijioke Nze, Ajlan Al Zaki, Francisco Vega, Michael Wang, Christopher R. Flowers, Luis Malpica
Journal: Blood
Blood (2024) 144 (Supplement 1): 1674.3.
https://doi.org/10.1182/blood-2024-212005
Published: 2024
Journal Articles

Radiation Therapy and Monocyte Activation in Large B-Cell Lymphoma Patients Treated with CAR T-Cell Therapy

Free
Penny Q. Fang, Susan Y. Wu, Jillian R. Gunther, Alena Frank, Pavel Zemskiy, Aleksandr Zaitsev, Evgenii S Bolshakov, Anastasiya Terenteva, Krystle Nomie, Michelly Abreu, Karla Ow, Minifrida Santiago, Jaimole Varghese, Amy Ayers, Jared Henderson, Sairah Ahmed, Jason R. Westin, Christopher R. Flowers, Sattva S. Neelapu, Bouthaina S. Dabaja, Chelsea C. Pinnix, Paolo Strati
Journal: Blood
Blood (2024) 144 (Supplement 1): 4377.
https://doi.org/10.1182/blood-2024-203844
Published: 2024
Journal Articles

Comprehensive Characterization and Validation of the Tumor Microenvironment in Patients with Relapsed/Refractory Large B-Cell Lymphoma Identifies Subgroups with Greatest Benefit from CD19 CAR T-Cell Therapy

Free
Xubin Li, Kartik Singhal, Qing Deng, Dai Chihara, David A Russler-Germain, Usama Hussein, Jennifer Ann Foltz, Jared Henderson, Ashley Wilson, Evelyn Schmidt, Imran A. Nizamuddin, Tommy Dinh, Ryan Sun, Akhil Kesaraju, Laura K. Hilton, David W. Scott, Francisco Vega, Christopher R. Flowers, Obi Griffith, Todd A Fehniger, Malachi Griffith, Michael R. Green
Journal: Blood
Blood (2024) 144 (Supplement 1): 643.
https://doi.org/10.1182/blood-2024-204166
Published: 2024
Journal Articles

Generation of a Patient Derived T-Cell Prolymphocytic Leukemia Xenograft Model to Evaluate Pre-Clinical Treatment with Small Molecule Inhibitors In Vivo

Free
Claudia Kettlun, Daniel Galvan, Jie Xu, Tania P Sainz Zuniga, Sebastian Juarez-Casillas, Daisy Y. Diaz Rohena, Vishal Sahu, Juan Andres Donoso, Arrate Zubero, Estela Rojas-Neira, David Blake, Jared Henderson, Michael Green, Tapan M. Kadia, Deepa Sampath, Francisco Vega
Journal: Blood
Blood (2024) 144 (Supplement 1): 4373.
https://doi.org/10.1182/blood-2024-193372
Published: 2024
Journal Articles

Germline Determinants of Toxicity and Efficacy in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 Autologous CAR T-Cell Therapy

Free
Paolo Strati, Amanda Brandt, Jared Henderson, Jason Westin, Loretta J. Nastoupil, Ajlan Al Zaki, Andrew P Jallouk, Sherry Adkins, Elizabeth J. Shpall, Partow Kebriaei, Jeremy Ramdial, Neeraj Y. Saini, Sairah Ahmed, Christopher R. Flowers, Sattva S. Neelapu, Michelle Hildebrandt
Journal: Blood
Blood (2023) 142 (Supplement 1): 5139.
https://doi.org/10.1182/blood-2023-180744
Published: 2023
Journal Articles

Addition of Acalabrutinib to Lenalidomide and Rituximab Induces High Complete Response Rates in Patients with Previously Untreated Follicular Lymphoma: Results of a Phase II Study

Free
Paolo Strati, Lei Feng, Jason Westin, Ranjit Nair, Luis Fayad, Maria Alma Rodriguez, Dai Chihara, Luis Malpica, Jared Henderson, Mariana Gallardo, Mario L. Marques-Piubelli, Polina Turova, Aleksandr Zaitsev, Iris Wang, Christopher R. Flowers, Loretta J. Nastoupil, Sattva S. Neelapu
Journal: Blood
Blood (2023) 142 (Supplement 1): 983.
https://doi.org/10.1182/blood-2023-180762
Published: 2023
Journal Articles

Initial Clinical Results and Immune Correlates of a Phase 2 Study of Daratumumab, Bortezomib, Dexamethasone Followed By a Proteasome Inhibitor in -Class Transition ( i CT) to Daratumumab, Ixazomib, Dexamethasone in Relapsed Refractory Multiple Myeloma

Free
Hans C. Lee, June Li, Heather Lin, Astrid D. Murga, Gabriela M Rodriguez, Mostafa E. Mohamed, Jared Henderson, Sarah Rodriguez, Melody R. Becnel, Donna M. Weber, Swami P. Iyer, Gregory P. Kaufman, Sheeba K. Thomas, Elisabet E. Manasanch, Krina K. Patel, Stephen J. Noga, Michael R. Green, Robert Z. Orlowski, Cara L Haymaker
Journal: Blood
Blood (2023) 142 (Supplement 1): 4760.
https://doi.org/10.1182/blood-2023-188201
Published: 2023
Journal Articles

Smart Stop: Lenalidomide, Tafasitamab, Rituximab, and Acalabrutinib Alone and with Combination Chemotherapy for the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma

Free
Jason Westin, Raphael E Steiner, Dai Chihara, Sairah Ahmed, Preetesh Jain, Luis Malpica, Swami P. Iyer, Luis Fayad, Ranjit Nair, Loretta J. Nastoupil, Sattva S. Neelapu, Jared Henderson, Maria Alma Rodriguez, F. B. Hagemeister, Francisco Vega, Brittani Pulsifer, Jisha Tom, Isak Durmic, Gita Masand, Lei Feng, Michael R. Green, Christopher R. Flowers, Paolo Strati
Journal: Blood
Blood (2023) 142 (Supplement 1): 856.
https://doi.org/10.1182/blood-2023-180381
Published: 2023
Journal Articles

A Phase II Study of Loncastuximab Tesirine As Consolidation Strategy in Patients with LBCL in PR at Day 30 after CAR T-Cell Therapy

Free
Ajlan Al Zaki, Lei Feng, Jason Westin, Ranjit Nair, Luis Fayad, Grace Watson, Sherry Adkins, Elizabeth J. Shpall, Mario L. Marques-Piubelli, Jared Henderson, Loretta J. Nastoupil, Christopher R. Flowers, Sairah Ahmed, Sattva S. Neelapu, Paolo Strati
Journal: Blood
Blood (2023) 142 (Supplement 1): 3098.
https://doi.org/10.1182/blood-2023-179004
Published: 2023
Journal Articles

DTX1 Controls Germinal Center B-Cell Development and Lymphomagenesis

Free
Atish Kizhakeyil, Sreejoyee Ghosh, Estela Rojas-Neira, Qing Deng, Jared Henderson, Jordan Showell, Ari Melnick, Wendy Beguelin, Francisco Vega, Loretta J. Nastoupil, Michael R Green
Journal: Blood
Blood (2022) 140 (Supplement 1): 1700–1701.
https://doi.org/10.1182/blood-2022-167086
Published: 2022
Journal Articles

Targetable Cellular Etiology of Prolonged Cytopenia Following CD19 CAR T-Cell Therapy

Free
Xubin Li, Qing Deng, Jared Henderson, Grace Watson, Laurel Deaton, Taylor Cain, Luis Fayad, Swaminathan Padmanabhan Iyer, Fredrick B. Hagemeister, Loretta J. Nastoupil, Nathan H. Fowler, Jason Westin, Raphael Steiner, Ranjit Nair, Sairah Ahmed, Gheath Alatrash, Sattva S. Neelapu, Paolo Strati, Michael R Green
Journal: Blood
Blood (2022) 140 (Supplement 1): 4502–4503.
https://doi.org/10.1182/blood-2022-166308
Published: 2022
Journal Articles

Smarca4 (Brg1) Controls Germinal Center B-Cell Development and Is a Haploinsufficient Tumor Suppressor in Lymphoma

Free
Qing Deng, Cem Meydan, Priya Lakra, Darko Barisic, Christopher R Chin, Estela Rojas-Neira, Vida Ravanmehr, Jared Henderson, Panhong Gou, Nader Kim El-Mallawany, Carl Allen, Branko Cuglievan, Francisco Vega, Christopher E Mason, Ari Melnick, Michael R Green
Journal: Blood
Blood (2022) 140 (Supplement 1): 1690–1691.
https://doi.org/10.1182/blood-2022-166258
Published: 2022
Journal Articles

Crebbp Kat Domain Missense Mutations Alter Its Dynamic Loading Onto Chromatin and Create a Transcription Factor Sink

Free
Haopeng Yang, Wenchao Zhang, Vida Ravanmehr, Jared Henderson, Qing Deng, Felipe Samaniego, Fernando Rodrigues-Lima, Michael R Green
Journal: Blood
Blood (2022) 140 (Supplement 1): 8768–8769.
https://doi.org/10.1182/blood-2022-166230
Published: 2022